Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

44,651 stories, page 609 of 745

Advanced search

🌍Jul 3discoverynews.google.comTier 3 · Aggregated media

Is Septerna, Inc. (SEPN) Stock a Biotech Opportunity With a Potential First-in-Class Hypoparathyroidism Treatment?

Yahoo FinanceOriginal source

🌍Jul 3discoverynews.google.comTier 3 · Aggregated media

Is Mineralys Therapeutics, Inc. (MLYS) Stock a Biotech Opportunity With Lorundrostat’s Expanding Cardiovascular Potential?

Yahoo FinanceOriginal source

🌍Jul 3discoverynews.google.comTier 3 · Aggregated media

FDA Names Donna Garren Director of Produce Safety

Quality Assurance & Food SafetyOriginal source

🌍Jul 3discoverynews.google.comTier 3 · Aggregated media

Biotech firms name new CEOs, leadership after BIO

BioProcess InternationalOriginal source

🌍Jul 3discoverynews.google.comTier 3 · Aggregated media

Alibaba to pay $600 million to U.S. for illegal pharmaceutical sales

upi.comOriginal source

🌍Jul 3discoverynews.google.comTier 3 · Aggregated media

More than 944,000 bottles of heart and kidney meds recalled nationwide

Houston ChronicleOriginal source

🌍Jul 3discoverynews.google.comTier 2 · Trade media

With New Phase 3 Data, Roche Claims an Edge Over Amgen and BMS Lung Cancer Drugs

MedCity NewsOriginal source

🌍Jul 3discoverynews.google.comTier 3 · Aggregated media

CAPR Stock In Spotlight As Investors Eye Next Week’s DMD Trial Data Showing Muscle And Cardiac Gains

StocktwitsOriginal source

🌍Jul 3discoverynews.google.comTier 3 · Aggregated media

AI-driven Drug Discovery Faces 2026 Test

Let's Data ScienceOriginal source

🌍Jul 3discoverynews.google.comTier 3 · Aggregated media

Amgen Inc Stock (AMGN) Moved Up by 3.01% on Jul 2: Key Drivers Unveiled

TradingKeyOriginal source

🌍Jul 3discoverynews.google.comTier 3 · Aggregated media

Biotech Gives SBIO Its Best Month Since 2023

ETF DatabaseOriginal source

🌍Jul 3Regulatorywho.intTier 1 · Regulatory source

Hantavirus outbreak linked to cruise ship travel, Multi-locations

WHO Disease Outbreak NewsOriginal source

🌍Jul 3discoverynews.google.comTier 3 · Aggregated media

AbbVie Inc Stock (ABBV) Moved Up by 3.44% on Jul 2: Drivers Behind the Movement

TradingKeyOriginal source

🌍Jul 3discoverynews.google.comTier 3 · Aggregated media

The Week’s 10 Biggest Funding Rounds: AI, Energy And Biotech Lead The Way

Crunchbase NewsOriginal source

🌍Jul 3discoverynews.google.comTier 3 · Aggregated media

The charts on this biotech stock look attractive, says Jay Woods

CNBCOriginal source

🌍Jul 3discoverynews.google.comTier 3 · Aggregated media

Medical services name tests for colon cancer. Natera stock hits a high

MSNOriginal source

🌍Jul 3Industrycuris.comTier 1 · Company source

Molecular Cancer Therapeutics: Improving Immune Checkpoint Blockade Efficacy in Melanoma Brain Metastases through Myddosomal inhibition with Emavusertib

CurisOriginal source

🌍Jul 3discoverynews.google.comTier 3 · Aggregated media

VERAXA Biotech Collaborates with ATUM on Cell Line Development to Advance Lead BiTAC®-TCE Program

citybizOriginal source

🇮🇹Jul 3Industryrecordati.comTier 1 · Company source

On behalf of Respighi BidCo S.p.A – Reopening of the review period

RecordatiOriginal source

🌍Jul 3discoverynews.google.comTier 3 · Aggregated media

Mexico City Unveils US$125 Million Biotech Investment Initiative

Mexico Business NewsOriginal source

🌍Jul 3discoverynews.google.comTier 3 · Aggregated media

Tenax Therapeutics Announces Late-Breaking Presentation of LEVEL Clinical Trial Data at ESC Congress 2026

Investing News NetworkOriginal source

🌍Jul 2discoverynews.google.comTier 2 · Trade media

Roche KRAS drug succeeds in head-to-head lung cancer study

BioPharma DiveOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

Dipanjan Pan, PhD, on early-stage tear biosensor research, closed-loop drug delivery, and the road to FDA clearance

Ophthalmology TimesOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

Glenmark advances Phase 3 trial of HER2-targeted ADC for platinum-resistant ovarian cancer

Indian Pharma PostOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

Nearly 1 Million Bottles of a Heart Failure Drug Were Just Recalled — Check Your Medicine Cabinet

Medical DailyOriginal source

🇺🇰Jul 2Regulatorygov.ukTier 1 · Regulatory source

Work-related quality of life of the adult social care workforce in England in 2025

Survey results from the second wave of the Adult Social Care Workforce Survey, undertaken between Au...

UK Department of Health and Social CareOriginal source

🌍Jul 2discoverynews.google.comTier 2 · Trade media

Biotech’s China problem: An issue of national security or economic value for the US?

BioSpaceOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

How Pitt’s BioForge kept a New York-based biotech startup’s presence in Pittsburgh

WPXIOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

West Pharmaceutical Services Stock Surges 13%, With A 9-Day Winning Spree

TrefisOriginal source

🌍Jul 2discoverynews.google.comTier 2 · Trade media

IPF biotech Celea gets $180M to follow paths of PureTech’s Karuna, Seaport

Endpoints NewsOriginal source

🌍Jul 2discoverynews.google.comTier 2 · Trade media

Roche drug sets new standard for KRAS-driven lung cancer

STATOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

Weekly Buzz: VRTX, APTX Gain FDA Nod; UNCY Disappoints; Ipsen Opens Wallet; VTGN Misses Goal

RTTNewsOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

Tenax Therapeutics to Present Phase 3 LEVEL Trial Results for Levosimendan in PH-HFpEF at ESC Congress 2026

MinichartOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

What a Brooklyn bodega reveals about the craze for an experimental weight-loss drug

CBS NewsOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

Trinity Biotech reports positive clinical findings for next-gen CGM

Drug Delivery BusinessOriginal source

🌍Jul 2discoverynews.google.comTier 2 · Trade media

FDA widens Vertex’s Casgevy use for paediatric patients

Pharmaceutical TechnologyOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

Trinity Biotech reports positive clinical findings for next-gen CGM

MassDeviceOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

Eisai to Showcase Alzheimer's Disease Portfolio with More Than 50 Presentations at the Alzheimer's Association International Conference(R) 2026 (AAIC(R))

ACN NewswireOriginal source

🌍Jul 2discoverynews.google.comTier 2 · Trade media

Ipsen bolsters rare disease pipeline in €700m Memo takeover

Pharmaceutical TechnologyOriginal source

🌍Jul 2discoverynews.google.comTier 2 · Trade media

7 FDA decisions to watch for in Q3

BioSpaceOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

Why animal models still matter in drug development

Drug Discovery NewsOriginal source

🇪🇺Jul 2Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Data driven Excellence in Training of Epidemiological, Clinical, Technological and Innovative Virus Experts

CORDISOriginal source

🇪🇺Jul 2Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Vaccinologists for Europe: Training network for developing next generation vaccines against mucosal pathogens

CORDISOriginal source

🇪🇺Jul 2Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Resolving the signal-to-noise ratio challenge for precision liquid biopsy and early solid tumor surveillance

CORDISOriginal source

🇪🇺Jul 2Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: A next-generation PCR tool for rapid and early diagnosis of sepsis aetiology

CORDISOriginal source

🇪🇺Jul 2Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Perturbation-based Phosphoproteomics to Study Drug Response Heterogeneity

CORDISOriginal source

🇪🇺Jul 2Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Precision oncology platform for personalised cannabinoid-based cancer therapies

CORDISOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

An extra 229,000 deaths: Is that the cost of US-UK drugs deal?

Al JazeeraOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

Biotech Pre-Market Pulse: LIMN, TENX, ELTX Swing Big

RTTNewsOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

The RWE Communication Gap That's Costing Manufacturers Formulary Access

Pharmaceutical CommerceOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

Trilogy Laboratories Acquires YNS Cosmeceuticals, Bringing Pharmaceutical Expertise and Physician Leadership to a Trusted Skincare Brand

Yahoo FinanceOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

Biotech Investor Pumps the Brakes on AI Drug Discovery

WSJOriginal source

🇺🇰Jul 2Researchmed.cam.ac.ukTier 2 · Direct publisher

Houdini Bio to unlock DNA limits with £1.5m pre-seed round

University of Cambridge - Clinical Medicine NewsOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

What's Driving Direct-to-Patient Model Adoption Across Pharma?

Pharmaceutical CommerceOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

Clinical Trial Helps Young Athlete Return to the Field, Highlighting Research at Locally-Based Kaiser Permanente

Pasadena NowOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

Jyong Biotech presents drug candidate at BIO 2026 convention

Investing.comOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

What to Expect From West Pharmaceutical Services' Q2 2026 Earnings Report

Barchart.comOriginal source

🌍Jul 2discoverynews.google.comTier 2 · Trade media

Fosun pays $32M to join Lilly and Novartis in fiercely competitive psoriasis market

Fierce BiotechOriginal source

🌍Jul 2discoverynews.google.comTier 2 · Trade media

Roche orchestrates phase 3 KRAS lung cancer win over Amgen, BMS

Fierce BiotechOriginal source

🌍Jul 2discoverynews.google.comTier 3 · Aggregated media

Revolution Medicines Presents Phase 1/2 Clinical Data for Zoldonrasib Combination Regimens in Patients with RAS G12D Metastatic Pancreatic Cancer at ESMO Gastrointestinal Cancers Congress 2026

The Manila TimesOriginal source